Inspector Douglas S Joslin''s approach focuses on ensuring the integrity and quality of drug products through a thorough evaluation of process validation, complaint management, CAPA, batch manufacturing, facility maintenance, change control, and data integrity management. He prioritizes detailed investigations and evidence of compliance in these areas.

FDA Investigator Douglas S Joslin has a keen focus on process validation, complaint management, corrective and preventive actions (CAPA), batch manufacturing, facility management, change control, and data integrity management. He emphasizes the criticality of ensuring batch consistency and quality, thorough complaint management, comprehensive investigation of discrepancies, proper testing and release procedures for drug product batches, facility maintenance to prevent contamination risks, robust change control procedures, and measures to ensure the integrity and accuracy of critical data.